2023
ICG Fluorescence Technique for Detection of Sentinel Lymph Nodes in Laparoscopic Endometrial Cancer Staging
AlAshqar A, Mutlu L, McNamara B, Harold J, Clark M, Huang G, Azodi M, Schwartz P, Santin A, Ratner E, Altwerger G, Andikyan V. ICG Fluorescence Technique for Detection of Sentinel Lymph Nodes in Laparoscopic Endometrial Cancer Staging. Journal Of Minimally Invasive Gynecology 2023, 30: s36. DOI: 10.1016/j.jmig.2023.08.110.Peer-Reviewed Original ResearchEndometrial cancer stagingSentinel lymph nodesLymph nodesCancer stagingSentinel lymph node identificationICG fluorescence techniqueTertiary care hospitalLymph node identificationICG techniqueSentinel lymphCare hospitalIntervention useStagingDye techniqueNode identificationLymphPatientsMalignancyHospitalEndoscopic Ultrasound in Cancer Staging
Aslanian H, Muniraj T, Nagar A, Parsons D. Endoscopic Ultrasound in Cancer Staging. Gastrointestinal Endoscopy Clinics Of North America 2023, 34: 37-49. PMID: 37973230, DOI: 10.1016/j.giec.2023.09.009.Peer-Reviewed Original Research
2022
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases
Asrani SK, Ghabril MS, Kuo A, Merriman RB, Morgan T, Parikh ND, Ovchinsky N, Kanwal F, Volk ML, Ho C, Serper M, Mehta S, Agopian V, Cabrera R, Chernyak V, El‐Serag H, Heimbach J, Ioannou GN, Kaplan D, Marrero J, Mehta N, Singal A, Salem R, Taddei T, Walling AM, Tapper EB. Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology 2022, 75: 1289-1299. PMID: 34778999, DOI: 10.1002/hep.32240.Peer-Reviewed Original ResearchConceptsPatient-reported outcomesHigh-risk populationHCC careCare continuumBarcelona Clinic Liver Cancer (BCLC) stagingData System (BI-RADS) 4 lesionsBurden of HCCLiver transplantation candidacyTumor board reviewLiver Imaging ReportingFear of treatmentStructured scoping reviewExplicit quality measuresAmerican AssociationTransplantation candidacyBest individual treatmentPalliative therapyGuideline recommendationsLiver diseaseAFP elevationAppropriate referralTreatment optionsTreatment recommendationsCancer stagingOutcome measures
2020
Lung Cancer Staging
Tanoue LT. Lung Cancer Staging. Clinics In Chest Medicine 2020, 41: 161-174. PMID: 32402353, DOI: 10.1016/j.ccm.2020.02.006.Peer-Reviewed Original ResearchConceptsAnatomic stagingStaging systemLung cancerAnatomic staging systemMultiple pulmonary sitesEvaluation of patientsExtent of diseaseLung cancer stagingMetastatic diseaseSurvival outcomesImmunologic informationPulmonary sitesPrimary tumorRegional nodesCancer stagingAppropriate careTNM componentsStagingCancerDiseasePatientsPrognosisTumorsEnvironment-level factorsCare
2019
The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors
Ruffini E, Fang W, Guerrera F, Huang J, Okumura M, Kim DK, Girard N, Billè A, Boubia S, Cangir AK, Detterbeck F, Falkson C, Filosso PL, Giaccone G, Kondo K, Infante M, Lucchi M, Marino M, Marom EM, Nicholson AG, Rimner A, Rami-Porta R, Asamura H, Committee S, Subcommittee S, Subcommittees S, Boards M. The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors. Journal Of Thoracic Oncology 2019, 15: 436-447. PMID: 31783179, DOI: 10.1016/j.jtho.2019.11.013.Peer-Reviewed Original ResearchConceptsTNM stage classificationAmerican Joint CommitteeThymic tumorsStaging systemT categoryN categoryJoint CommitteeInternational Cancer Control/American Joint CommitteeMasaoka-Koga staging systemMediastinal pleural involvementLymph node dissectionWeb-based cross-sectional surveyLung cancer stagingInternational Cancer ControlCross-sectional surveyNode dissectionPleural involvementThymic carcinomaTNM classificationTNM systemCancer controlCancer stagingThoracic communityWeb-based questionnaireStage classificationEndoscopic Ultrasound for the Diagnosis and Staging of Liver Tumors
Lange A, Muniraj T, Aslanian HR. Endoscopic Ultrasound for the Diagnosis and Staging of Liver Tumors. Gastrointestinal Endoscopy Clinics Of North America 2019, 29: 339-350. PMID: 30846157, DOI: 10.1016/j.giec.2018.12.005.Peer-Reviewed Original ResearchConceptsEndoscopic ultrasound examinationUltrasound examinationFine-needle aspirationPortal veinNeedle aspirationLiver lesionsCross-sectional imagingIndeterminate liver lesionsFocal liver lesionsLocoregional nodesLymph nodesLiver malignanciesCancer stagingEndoscopic ultrasoundLiver tumorsTechnologic improvementsLesionsExaminationStagingDiagnosisVeinAspirationMalignancyTumorsLiver
2018
P3.03-24 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging
Haro G, Kratz J, Cook N, He J, Van Den Eeden S, Woodard G, Gubens M, Jahan T, Jones K, Kim I, He B, Jablons D, Mann M. P3.03-24 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging. Journal Of Thoracic Oncology 2018, 13: s919. DOI: 10.1016/j.jtho.2018.08.1701.Peer-Reviewed Original ResearchRare Presentation of Squamous Cell Carcinoma of the Foot in a Noncompliant HIV+ Patient.
Sedberry SD, Gazes MI, Zellner E, Vyce SD. Rare Presentation of Squamous Cell Carcinoma of the Foot in a Noncompliant HIV+ Patient. WOUNDS A Compendium Of Clinical Research And Practice 2018, 30: e68-e70. PMID: 30059340.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaCell carcinomaInguinal lymph node metastasisPrimary squamous cell carcinomaPositron emission tomography/Active antiretroviral therapyLymph node metastasisHuman immunodeficiency virusPhantom limb painSun-damaged skinExtent of infectionAntiretroviral therapyTransmetatarsal amputationNode metastasisLimb painRare presentationSurgical findingsImmunodeficiency virusImmunosuppressed individualsEmergency departmentTomography/Surgical woundsTomography scanCancer stagingLeft legSorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma
Kaplan DE, Mehta R, D’Addeo K, Valderrama A, Taddei TH. Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma. Medicine 2018, 97: e9757. PMID: 29369224, PMCID: PMC5794408, DOI: 10.1097/md.0000000000009757.Peer-Reviewed Original ResearchConceptsAdvanced hepatocellular carcinomaHepatocellular carcinomaOverall survivalBarcelona Clinic Liver Cancer (BCLC) systemManagement of HCCVeterans Health Administration hospitalsRetrospective cohort studyFirst-line therapySimilar survival outcomesChild-TurcottePugh scoreComorbidity indexChart abstractionCohort studySurvival benefitSystemic therapyBCLC stagePrimary outcomePrescriber typeSurvival outcomesAdministration HospitalMultivariable modelProvider specialtyCancer stagingHCC diagnosis
2016
Electronic Intervention to Improve Structured Cancer Stage Data Capture
Cecchini M, Framski K, Lazette P, Vega T, Strait M, Adelson K. Electronic Intervention to Improve Structured Cancer Stage Data Capture. JCO Oncology Practice 2016, 12: e949-e956. PMID: 27650837, DOI: 10.1200/jop.2016.013540.Peer-Reviewed Original ResearchConceptsStaging rateElectronic health recordsCancer stageClinical trial eligibilityElectronic decision supportTrial eligibilityMonths postinterventionCancer stagingPhysician useClinical notesBPA implementationProblem listHealth recordsElectronic interventionMonthsTreatment planningCancerStagingPhysiciansAct methodologyInterventionUnstructured free textHard stopBPAPatientsThe IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, Mazzone PJ, Marom EM, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R, Committee I, Goldstraw P, Rami-Porta R, Asamura H, Ball D, Beer D, Beyruti R, Bolejack V, Chansky K, Crowley J, Detterbeck F, Eberhardt W, Edwards J, Galateau-Sallé F, Giroux D, Gleeson F, Groome P, Huang J, Kennedy C, Kim J, Kim Y, Kingsbury L, Kondo H, Krasnik M, Kubota K, Lerut A, Lyons G, Marino M, Marom E, van Meerbeeck J, Mitchell A, Nakano T, Nicholson A, Nowak A, Peake M, Rice T, Rosenzweig K, Ruffini E, Rusch V, Saijo N, Van Schil P, Sculier J, Shemanski L, Stratton K, Suzuki K, Tachimori Y, Thomas C, Travis W, Tsao M, Turrisi A, Vansteenkiste J, Watanabe H, Wu Y, Boards A, Baas P, Erasmus J, Hasegawa S, Inai K, Kernstine K, Kindler H, Krug L, Nackaerts K, Pass H, Rice D, Falkson C, Filosso P, Giaccone G, Kondo K, Lucchi M, Okumura M, Blackstone E, Workgroup M, Flieder D, Godoy M, Goo J, Goodman L, Jett J, de Leyn P, Marchevsky A, MacMahon H, Naidich D, Okada M, Perlman M, Powell C, van Schil P, Warth A. The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. Journal Of Thoracic Oncology 2016, 11: 651-665. PMID: 26944304, DOI: 10.1016/j.jtho.2016.01.025.Peer-Reviewed Original ResearchConceptsPrimary lung cancerSecond primary lung cancerSeparate primary lung cancersLung cancerIASLC Lung Cancer Staging ProjectLung Cancer Staging ProjectForthcoming Eighth EditionOutcomes of patientsMultidisciplinary tumor boardLung cancer stagingComprehensive histologic assessmentHistologic cancer typesAbsence of biomarkersMechanisms of metastasisPrognostic Factors CommitteeNodal involvementTNM classificationMetastatic fociPathologic criteriaPulmonary sitesSecond primaryHistologic assessmentTumor boardCancer stagingLung tumorsAn electronic intervention to improve structured cancer stage data capture.
Adelson K, Framski K, Lazette P, Vega T, Lilenbaum R. An electronic intervention to improve structured cancer stage data capture. Journal Of Clinical Oncology 2016, 34: 151-151. DOI: 10.1200/jco.2016.34.7_suppl.151.Peer-Reviewed Original ResearchTumor RegistryCancer stagingOutcome analysisClinical trial eligibility determinationDisease-free intervalPalliative care consultationClinical trial eligibilityNumber of patientsElectronic decision supportEligible patientsTrial eligibilityAdvanced diseaseOverall survivalCare consultationsCancer CommitteeFree intervalCancer stageClinical trialsLung measuresClinical notesPatientsRegistry reportingStagingCancerElectronic intervention
2015
4:33 PM, Abstract No. 54 FEATURED ABSTRACT, Hong Kong liver cancer staging outperforms Barcelona clinic liver cancer staging as a prognostic classification system in patients treated with intra-arterial therapy: a North American study
Sohn J, Duran R, Lee H, Sahu S, Schernthaner R, Zhao L, Lin M, Fleckenstein F, Zhao Y, Geschwind J. 4:33 PM, Abstract No. 54 FEATURED ABSTRACT, Hong Kong liver cancer staging outperforms Barcelona clinic liver cancer staging as a prognostic classification system in patients treated with intra-arterial therapy: a North American study. Journal Of Vascular And Interventional Radiology 2015, 26: s30. DOI: 10.1016/j.jvir.2014.12.086.Peer-Reviewed Original Research
2011
MicroRNA Expression Characterizes Oligometastasis(es)
Lussier YA, Xing HR, Salama JK, Khodarev NN, Huang Y, Zhang Q, Khan SA, Yang X, Hasselle MD, Darga TE, Malik R, Fan H, Perakis S, Filippo M, Corbin K, Lee Y, Posner MC, Chmura SJ, Hellman S, Weichselbaum RR. MicroRNA Expression Characterizes Oligometastasis(es). PLOS ONE 2011, 6: e28650. PMID: 22174856, PMCID: PMC3236765, DOI: 10.1371/journal.pone.0028650.Peer-Reviewed Original ResearchConceptsOligometastatic patientsMetastasis-directed treatmentMetastasis-directed therapyHigh-dose radiotherapyPredictors of progressionMicroRNA-200 (miR-200) familyPolymetastatic progressionMetastatic diseasePatient selectionLocal treatmentCancer stagingMetastatic outcomeXenograft modelMicroRNA classifierPatientsPolymetastasesTumor samplesOligometastasesCell linesTreatmentProgressionBiological basisRadiotherapyExpressionTherapy
2010
To Count and How to Count, That Is the Question
Parkash V, Bifulco C, Feinn R, Concato J, Jain D. To Count and How to Count, That Is the Question. American Journal Of Clinical Pathology 2010, 134: 42-49. PMID: 20551265, DOI: 10.1309/ajcpo92dzmucgeuf.Peer-Reviewed Original Research
2008
MR Imaging in Diagnosis and Staging of Pulmonary Carcinoma
Godelman A, Haramati L. MR Imaging in Diagnosis and Staging of Pulmonary Carcinoma. Magnetic Resonance Imaging Clinics Of North America 2008, 16: 309-317. PMID: 18474334, DOI: 10.1016/j.mric.2008.02.013.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
1989
Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
Spiegelman D, Maurer LH, Ware JH, Perry MC, Chahinian AP, Comis R, Eaton W, Zimmer B, Green M. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. Journal Of Clinical Oncology 1989, 7: 344-54. PMID: 2537384, DOI: 10.1200/jco.1989.7.3.344.Peer-Reviewed Original ResearchConceptsLong-term survivalPerformance statusOverall survivalPrognostic factorsED patientsMetastatic sitesLung cancerExtensive small cell lung cancerResponse rateSmall cell lung cancerFailure-free survivalOverall objective responseLead-time biasLeukemia Group BPretreatment prognostic factorsSmall cell carcinomaLung cancer stagingImproved response ratesPercentage of womenObjective responseSupraclavicular lymphPatient populationLD patientsCancer stagingFemale gender
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply